Welcome to our dedicated page for Gohealth news (Ticker: GOCO), a resource for investors and traders seeking the latest updates and insights on Gohealth stock.
GoHealth, Inc. reports developments in its Medicare-focused health insurance marketplace, where proprietary technology and licensed agents support consumer plan comparison and enrollment. News about GOCO commonly covers Medicare Advantage market conditions, Annual Enrollment Period activity, PlanFit technology, Special Needs Plans, retention initiatives, and the company’s efforts to match consumers with coverage suited to their needs.
Company updates also address quarterly and annual results, revenue mix, commission receivables, back-book durability, liquidity, cost discipline, automation and AI investments, and capital or governance actions. Recent coverage has emphasized a more disciplined Medicare Advantage posture, member quality, renewal economics, and strategic flexibility.
GoHealth, Inc. (NASDAQ: GOCO) has announced its upcoming financial results for Q1 2022, set to be released on May 10, 2022, at 4:00 p.m. (ET). A conference call will follow at 5:00 p.m. (ET) to discuss these results. Interested parties can join the call by dialing 866-374-5140 with the conference ID 60724445. GoHealth focuses on improving healthcare access in the U.S. through its digital health platform and has assisted millions in enrolling in Medicare and other health plans.
GoHealth, Inc. (Nasdaq: GOCO) reported its financial results for Q4 and FY2021, highlighting a net revenue of $449.6 million in Q4, up 1%, and FY2021 net revenue of $1,062.4 million, up 21%. However, the company faced significant net losses of $432.3 million in Q4 and $534.2 million for the year, influenced by goodwill impairments. Adjusted EBITDA plummeted by 99% in Q4 to $1.5 million. Looking ahead, GoHealth expects 2022 net revenue between $900 million and $1.1 billion, and Adjusted EBITDA of $110 to $150 million, signaling potential recovery amidst challenges.
GoHealth, Inc. (GOCO) will release its financial results for Q4 and the fiscal year ending December 31, 2021, on March 15, 2022, at 4:00 p.m. ET. A conference call to discuss these results is scheduled for 5:00 p.m. ET. Investors can access the live audio webcast via GoHealth's Investor Relations website. The company aims to enhance healthcare access in America through its health insurance marketplace, leveraging technology and industry expertise to match customers with suitable healthcare plans.
GoHealth, Inc. (Nasdaq: GOCO) announced preliminary financial results for Q4 and FY 2021, indicating net revenue expectations of $425-$470 million for Q4, up from $445.9 million in Q4 2020. FY 2021 revenue is projected between $1.040-$1.085 billion, significantly surpassing $877.4 million last year but below prior guidance. The company expects a net loss of $52.7-$38.8 million for Q4 and $155-$141 million for the year, contrasting with net income of $133.1 million and $97.2 million respectively in 2020. Goodwill impairment charges and financial covenant compliance issues are anticipated.
GoHealth, Inc. (NASDAQ: GOCO) has been recognized in Built In's 2022 list of the 100 Best Places to Work in Chicago. The company’s commitment to a healthy work-life balance, employee benefits, and mentorship programs contributed to this accolade. CEO Clint Jones emphasized GoHealth's focus on rewarding employees and noted its growth during the pandemic. Built In uses data-driven metrics encompassing compensation, benefits, culture, and diversity to rank companies, making the list a valuable resource for job seekers in tech.
On December 21, 2021, GoHealth (NASDAQ: GOCO) announced the granting of equity-based awards to newly appointed CFO Vance Johnston under its 2021 Inducement Award Plan. The approval was made by independent directors and aimed to incentivize Johnston's employment acceptance. The awards include a non-statutory option to purchase 438,099 shares at an exercise price of $3.55, along with 281,690 restricted stock units (RSUs). Both options and RSUs will vest over three years, contingent upon Johnston's continued service.
On December 6, 2021, GoHealth (NASDAQ: GOCO) announced the appointment of Vance Johnston as Chief Financial Officer, effective December 7. Johnston, who has held CFO roles in various public companies, will work alongside Travis Matthiesen, the current CFO transitioning to Chief Transformation Officer. CEO Clint Jones expressed confidence in Johnston's expertise to bolster the company's focus on growth and shareholder value. GoHealth, a leader in health insurance, aims to enhance healthcare access through tech and data science.
GoHealth, Inc. (NASDAQ: GOCO) will participate in the 4th Annual Evercore ISI HealthCONx Conference on December 2, 2021, at 8 a.m. ET. Co-founder and CEO Clint Jones and CFO Travis Matthiesen will discuss the company's business strategy. A live audio webcast will be available on GoHealth's Investor Relations website, and a recording will follow the event. GoHealth, a leader in the health insurance marketplace, aims to improve healthcare access in America through technology and industry expertise.
Summary not available.
GoHealth, Inc. (NASDAQ: GOCO) announced Q3 2021 results, reporting net revenue of $211.7 million, a 30% increase year-over-year. Year-to-date net revenue reached $612.8 million, up 42%. Medicare—Internal revenue for Q3 was $158.6 million, a 19% increase, while year-to-date reached $476.4 million (up 51%). However, the company reported a net loss of $55.4 million for Q3. The outlook for full-year 2021 remains positive, estimating net revenue between $1,200 and $1,300 million, an increase of 37%-48%.